ZA200706254B - 18-methyl-19-nor-17-pregn-4-en-21,17-carbolactones and pharmaceutical preparations comprising the same - Google Patents

18-methyl-19-nor-17-pregn-4-en-21,17-carbolactones and pharmaceutical preparations comprising the same

Info

Publication number
ZA200706254B
ZA200706254B ZA200706254A ZA200706254A ZA200706254B ZA 200706254 B ZA200706254 B ZA 200706254B ZA 200706254 A ZA200706254 A ZA 200706254A ZA 200706254 A ZA200706254 A ZA 200706254A ZA 200706254 B ZA200706254 B ZA 200706254B
Authority
ZA
South Africa
Prior art keywords
carbolactones
pregn
methyl
same
pharmaceutical preparations
Prior art date
Application number
ZA200706254A
Other languages
English (en)
Inventor
Bohlmann Rolf
Kuenzer Hermann
Muhn Hans-Peter
Fuhrmann Ulrike
Borden Steffen
Bitler Dieter
Esperling Peter
Fritzemeier Karl-Heinrich
Prelle Katja
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36087369&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200706254(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of ZA200706254B publication Critical patent/ZA200706254B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C07J53/004—3 membered carbocyclic rings
    • C07J53/008—3 membered carbocyclic rings in position 15/16

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ZA200706254A 2004-12-30 2007-07-27 18-methyl-19-nor-17-pregn-4-en-21,17-carbolactones and pharmaceutical preparations comprising the same ZA200706254B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004063864A DE102004063864A1 (de) 2004-12-30 2004-12-30 18-Methyl-19-nor-17-pregn-4-en21,17-carbolactone, sowie diese enthaltende pharmazeutische Präparate

Publications (1)

Publication Number Publication Date
ZA200706254B true ZA200706254B (en) 2008-12-31

Family

ID=36087369

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200706254A ZA200706254B (en) 2004-12-30 2007-07-27 18-methyl-19-nor-17-pregn-4-en-21,17-carbolactones and pharmaceutical preparations comprising the same

Country Status (32)

Country Link
US (1) US20090029953A1 (fr)
EP (1) EP1831240B8 (fr)
JP (1) JP5043681B2 (fr)
KR (1) KR20070093443A (fr)
CN (1) CN101128476B (fr)
AR (1) AR052657A1 (fr)
AU (1) AU2005324055A1 (fr)
BR (1) BRPI0518533A2 (fr)
CA (1) CA2594171C (fr)
CR (1) CR9223A (fr)
CY (1) CY1109498T1 (fr)
DE (2) DE102004063864A1 (fr)
DK (1) DK1831240T3 (fr)
EA (1) EA014325B1 (fr)
ES (1) ES2331322T3 (fr)
GT (1) GT200500394A (fr)
IL (1) IL184288A (fr)
MX (1) MX2007008074A (fr)
MY (1) MY145904A (fr)
NO (1) NO20073257L (fr)
NZ (1) NZ556150A (fr)
PA (1) PA8658401A1 (fr)
PE (2) PE20100736A1 (fr)
PL (1) PL1831240T3 (fr)
PT (1) PT1831240E (fr)
RS (1) RS51128B (fr)
SI (1) SI1831240T1 (fr)
TW (1) TW200635942A (fr)
UA (1) UA90496C2 (fr)
UY (1) UY29320A1 (fr)
WO (1) WO2006072467A1 (fr)
ZA (1) ZA200706254B (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006030416A1 (de) * 2006-06-29 2008-01-03 Bayer Schering Pharma Ag 18-Methyl-19-nor-androst-4-en-17,17-spiroether (18-Methyl-19-nor-20-spirox-4-en-3-one) sowie diese enthaltende pharmazeutische Präparate
DE102007027637A1 (de) 2007-06-12 2008-12-18 Bayer Schering Pharma Aktiengesellschaft 17ß-Cyano-19-nor-androst-4-en-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
DE102007027636A1 (de) 2007-06-12 2008-12-18 Bayer Schering Pharma Aktiengesellschaft 17ß-Cyano-18a-homo-19-nor-androst-4-en-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
DE102007027635A1 (de) * 2007-06-12 2008-12-18 Bayer Schering Pharma Aktiengesellschaft 17ß-Cyano-19-androst-4-en-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
DE102007063503A1 (de) * 2007-12-29 2009-07-02 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-19-nor-21-carbonsäure-Steroid y-Lacton-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
DE102007063501A1 (de) * 2007-12-29 2009-07-02 Bayer Schering Pharma Aktiengesellschaft 15, 16-Methylen-17-hydroxy-19-nor-21-carbonsäure-Steroid y-Lacton-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
DE102007063498A1 (de) * 2007-12-29 2009-07-02 Bayer Schering Pharma Aktiengesellschaft 15,16-Methylen-steroid-17,17-Lactol-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
DE102007063499A1 (de) * 2007-12-29 2009-07-02 Bayer Schering Pharma Aktiengesellschaft Steroid-17,17-Lactol-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
DE102007063495A1 (de) * 2007-12-29 2009-09-17 Bayer Schering Pharma Aktiengesellschaft 19-Nor-Steroidderivate mit einer 15α,16α-Methylengruppe und einem gesättigten 17,17-Spirolactonring, deren Verwendung sowie diese Derivate enthaltende Arzneimittel
DE102007063496A1 (de) 2007-12-29 2009-07-02 Bayer Schering Pharma Aktiengesellschaft 15,16-Methylen-17-(1'-propenyl)-17-3'-oxidoestra-4-en-3-on-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
DE102007063500A1 (de) * 2007-12-29 2009-07-02 Bayer Schering Pharma Aktiengesellschaft 17-(1'-Propenyl)-17-3'-oxidoestra-4-en-3-on-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
WO2009111574A2 (fr) * 2008-03-05 2009-09-11 Evestra, Inc. Carbolactones de bisméthylène-17α et utilisations associées
DE102008026793A1 (de) 2008-06-02 2009-12-03 Bayer Schering Pharma Aktiengesellschaft C-Ring-substituierte Pregn-4-en-21,17-carbolactone, sowie diese enthaltende pharmazeutische Präparate
CN101623287B (zh) * 2008-07-07 2012-02-08 天津金耀集团有限公司 一种屈螺酮类似物的治疗更年期综合症的药物组合物
EP2367808A4 (fr) * 2008-11-25 2012-05-09 Evestra Inc g-LACTONES D'ACIDE 3-(6,6-ÉTHYLÈNE-17b-HYDROXY-3-OXO-17a-PRÉGNA-4-ÈNE-17a-YL) PROPIONIQUE PROGESTATIVES
WO2010066355A1 (fr) * 2008-12-12 2010-06-17 Bayer Schering Pharma Aktiengesellschaft UTILISATION DE DÉRIVÉS DE 17β- CYANO-19-NOR-ANDROST-4-ÈNE POUR PRODUIRE UN MÉDICAMENT À LIBÉRATION PROLONGÉE DESTINÉ À ÊTRE ADMINISTRÉ PAR VOIE PARENTÉRALE, ET MÉDICAMENT À LIBÉRATION PROLONGÉE CONTENANT DES DÉRIVÉS DE 17β- CYANO-19-NOR-ANDROST-4-ÈNE DESTINÉ À ÊTRE ADMINISTRÉ PAR VOIE PARENTÉRALE
WO2010066354A1 (fr) * 2008-12-12 2010-06-17 Bayer Schering Pharma Aktiengesellschaft UTILISATION DE DÉRIVÉS DE 17β-CYANO-18A-HOMO-19-NOR-ANDROST-4-ÈNE POUR PRODUIRE UN MÉDICAMENT À LIBÉRATION PROLONGÉE DESTINÉ À ÊTRE ADMINISTRÉ PAR VOIE PARENTÉRALE, ET MÉDICAMENT À LIBÉRATION PROLONGÉE CONTENANT DES DÉRIVÉS DE 17β-CYANO-18A-HOMO-19-NOR-ANDROST-4-ÈNE DESTINÉ À ÊTRE ADMINISTRÉ PAR VOIE PARENTÉRALE
WO2010066349A1 (fr) * 2008-12-12 2010-06-17 Bayer Schering Pharma Aktiengesellschaft UTILISATION DE DÉRIVÉS DE 17β-CYANO-19-ANDROST-4-ÈNE POUR PRODUIRE UN MÉDICAMENT À LIBÉRATION PROLONGÉE DESTINÉ À ÊTRE ADMINISTRÉ PAR VOIE PARENTÉRALE, ET MÉDICAMENT À LIBÉRATION PROLONGÉE CONTENANT DES DÉRIVÉS DE 17β-CYANO-19-ANDROST-4-ÈNE DESTINÉ À ÊTRE ADMINISTRÉ PAR VOIE PARENTÉRALE
WO2012059594A1 (fr) 2010-11-04 2012-05-10 Bayer Pharma Aktiengesellschaft Antagonistes de récepteur de minéralocorticoïde pour le traitement de l'obésité induite par corticoïde

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3959322A (en) * 1960-09-22 1976-05-25 Herchel Smith Synthesis of 13-alkyl-gon-4-ones
DE3022337A1 (de) * 1980-06-11 1982-01-07 Schering Ag Berlin Und Bergkamen, 1000 Berlin Praeparate zur kontrazeption und zur behandlung gynaekologischer stoerungen
DE3402329A1 (de) * 1984-01-20 1985-08-01 Schering AG, 1000 Berlin und 4709 Bergkamen 6,6-ethylen-15,16-methylen-3-oxo-17(alpha)-pregn-4-en-21,17-carbolactone, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate
FR2739029B1 (fr) * 1995-09-21 1997-11-21 Roussel Uclaf Nouvelle application therapeutique des composes antimineralo-corticoides
DE19651000A1 (de) * 1996-12-01 1998-06-04 Schering Ag Oxyiminopregnancarbolactone

Also Published As

Publication number Publication date
US20090029953A1 (en) 2009-01-29
TW200635942A (en) 2006-10-16
CR9223A (es) 2007-11-23
NO20073257L (no) 2007-08-29
EP1831240B1 (fr) 2009-07-15
CA2594171A1 (fr) 2006-07-13
JP5043681B2 (ja) 2012-10-10
IL184288A0 (en) 2007-10-31
EP1831240A1 (fr) 2007-09-12
EA014325B1 (ru) 2010-10-29
PE20060853A1 (es) 2006-09-15
AU2005324055A1 (en) 2006-07-13
UY29320A1 (es) 2006-07-31
CN101128476A (zh) 2008-02-20
BRPI0518533A2 (pt) 2008-11-25
EA200701239A1 (ru) 2007-12-28
RS51128B (sr) 2010-10-31
PL1831240T3 (pl) 2010-01-29
SI1831240T1 (sl) 2009-12-31
WO2006072467A1 (fr) 2006-07-13
EP1831240B8 (fr) 2010-02-17
KR20070093443A (ko) 2007-09-18
MX2007008074A (es) 2008-03-10
DE102004063864A1 (de) 2006-07-13
JP2008526709A (ja) 2008-07-24
CY1109498T1 (el) 2014-08-13
MY145904A (en) 2012-05-15
GT200500394A (es) 2006-08-01
CN101128476B (zh) 2011-02-09
DE502005007723D1 (de) 2009-08-27
DK1831240T3 (da) 2009-11-23
ES2331322T3 (es) 2009-12-29
NZ556150A (en) 2011-02-25
UA90496C2 (ru) 2010-05-11
HK1112627A1 (en) 2008-09-12
PT1831240E (pt) 2009-10-22
PE20100736A1 (es) 2010-12-03
CA2594171C (fr) 2012-10-16
AR052657A1 (es) 2007-03-28
PA8658401A1 (es) 2006-08-03
IL184288A (en) 2011-06-30

Similar Documents

Publication Publication Date Title
IL184288A0 (en) 18-methyl-19-nor-17-pregn-4-en-21,17-carbolactones and pharmaceutical preparations comprising the same
TWI347201B (en) Pharmaceutical products,uses thereof and methods for preparing the same
IL181964A0 (en) Medicaments comprising carbonyl compounds, and the use thereof
EP1784163A4 (fr) Nanoemulsion, son utilisation et son procede de preparation
IL209494A (en) Formulations of insulin oligomeric monoconogues and their use
PL378135A1 (pl) 2-Cyjanopirolopirymidyny i ich zastosowania w farmaceutykach
ZA200407868B (en) 17alpha-Alkyl-17beta-oxy-estratrienes, uses thereof and pharmaceutical preparations.
IL178402A0 (en) 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof
IL182624A0 (en) 2-amido-4 phenylthiazole derivatives, the preparation and the therapeutic use thereof
IL195935A0 (en) 18-methyl-19-nor-androst-4-en 17,17-spiroether (18-methyl-19-nor-20-spirox-4-en-3-one) and pharmaceutical preparations containing the same
EP1731524A4 (fr) Derive phenole, composition medicinale contenant ce derive, et son usage medicinal
PL394604A1 (pl) Pochodna winyloazacykloalkanowa, jej zastosowanie oraz kompozycja farmaceutyczna
IL174479A (en) The derivatives of myastrin, pharmaceutical preparations containing them and their uses
GB0420062D0 (en) Assay methods,materials and preparations
EP1873147A4 (fr) Derive de phtalazinone et produit pharmaceutique le comprenant
IL180894A0 (en) 1-??-halo-2,2-difluoro-2-deoxy-d-ribofuranose derivatives and processes for the preparation thereof
IL177223A (en) Tat complexes, vaccines containing them and their uses
ZA200408787B (en) Pharmaceutical combination.
TWI340642B (en) Acylaminothiazole derivatives, preparation and therapeutic application thereof
EP1829860A4 (fr) Dérivé de 9,10-secoprégnane et médicament le contenant
ZA200605483B (en) Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
IL176509A0 (en) Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
GB0409770D0 (en) Pharmaceutical preparations and their uses
Lallanilla The Flu and You--Common Sense May Be the Best Medicine
GB0508767D0 (en) Pharmaceutical preparations and their uses